Navigation Links
New Study on HIV/AIDS Redefines the Size, Scale, and Scope of Epidemic
Date:1/19/2011

CAMBRIDGE, Mass., Jan. 19, 2011 /PRNewswire/ -- Health Alert Communications, www.healthalert.net, announces the publication of its groundbreaking report, HIV/AIDS: The Jennings Report – Redefining the Size, Scope, and Scale of the AIDS Epidemic by Forensic Review of the Medical Literature, available from MarketResearch.com and ResearchAndMarkets.com, the world's leading distributors of market intelligence.

The report synthesizes the scientific and medical literature to conceptually redefine the size of the AIDS epidemic and related markets:  a potentially invaluable, alternative perspective for decision-makers responsible for funding endeavors related to HIV-related products and/or interventions.

HIV/AIDS: The Jennings Report distills the knowledge garnered from a forensic review of the medical literature – over 3,000 scientific and medical articles – the collaborative efforts of thousands of scientists spanning 30 years. This document reports on all the relevant disciplines relating to HIV/AIDS, presenting information previously overlooked, and reconfiguring the medical and scientific data into a new conceptual constellation.  The precision of this qualitative information sloughs away many long-lived misconceptions, and confutes the theorems upon which the quantitative statistical models are based.

"A series of interlocking fallacies have distorted scientific and public perceptions of HIV and the AIDS epidemic, such that scientific and medical data are viewed through a warped lens," says Chris Jennings, Author and Proprietor of Health Alert Communications.  "The scientific literature is clear:  (1) New York City is the epicenter of the AIDS epidemic; (2) the theory that HIV came from monkeys is a fallacy (the theory that AIDS originated in African monkeys arose from an incident of laboratory contamination); and (3) the African AIDS epidemic-as-holocaust never manifested."

The information presented by HIV/AIDS: The Jennings Report has powerful implications that could affect funding and research prerogatives, potentially enabling more practical allocation of resources.

HIV/AIDS: The Jennings Report is available at:  http://www.marketresearch.com/product/display.asp?xs=r&productid=2879615 and http://www.researchandmarkets.net/reportinfo.asp?r=1477240.  Both websites provide a Table of Contents.

About Health Alert Communications: (www.healthalert.net) published two AIDS books, one favorably reviewed by the New England Journal of Medicine, that sold over 165,000:  both adopted as reference texts by world-renowned hospitals; city, state, and federal health agencies; colleges, nursing schools, and public health schools; and medical bookstores.

About Chris Jennings:  www.healthalert.net/Chris_Jennings.html

About MarketResearch.com:  www.marketresearch.com/corporate/aboutus/default.asp?SID=57797214-499932699-515748933

About ResearchAndMarkets.com:  www.researchandmarkets.com/info/about.aspContacts:Jacki Katzman Health Alert Communications+ 1.781.223.1364pr@healthalert.net
'/>"/>

SOURCE Health Alert Communications
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Groundbreaking Study Showed Bayers Advantage Multi® for Dogs (imidacloprid + moxidectin) Topical Solution was the only Heartworm Preventive Tested That Demonstrated 100 Percent Efficacy against the Challenging MP3 Strain
2. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
3. Long Term Care Pharmacy Alliance Concerned with Proposed CMS Rule; New Study Confirms LTCPA Position
4. St. Francis Hospital to be Part of Major Nationwide Study Using a Catheter-Based Aortic Valve Replacement
5. CVS Caremark Study Finds Patients with Complex Therapies Struggle to Stay Adherent to their Medications
6. Chimerix Commences CMX001 Open-Label Clinical Study for the Treatment of Patients With Life-Threatening or Serious dsDNA Viral Infections
7. Esperion Therapeutics Initiates Phase 2 Clinical Study for ETC-1002
8. CVS Caremark Study Finds Medication Adherence Leads to Lower Health Care Costs, Even After Accounting for Increased Prescription Drug Spending
9. Altheus Therapeutics Completes Phase I Clinical Study of Zoenasa™ in Ulcerative Colitis
10. Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients
11. Carbylan BioSurgery Completes Enrollment in Key Clinical Feasibility Study of Hydros and Hydros TA in Patients With Pain From Knee Osteoarthritis; Core Patent Issued
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... , April 27, 2016 Transparency ... "Skincare Devices Market - Global Industry Analysis, Size, Share, ... the report, the global skincare devices market was valued ... to expand at a CAGR of 10.1% from 2015 ... Browse the full Skincare Devices Market (Treatment Device ...
(Date:4/27/2016)... Kan. , April 27, 2016  Bayer ... , a senior from the University of Florida ... of the Bayer Excellence in Communication Award (BECA). ... schools, which were awarded a total of $70,000 ... the last four years, Bayer has provided a ...
(Date:4/27/2016)... April 27, 2016 Oasmia ... developer of a new generation of drugs within ... survival results for Paclical/Apealea in the Phase III ... with epithelial ovarian cancer. These preliminary results showed ... combination with carboplatin versus Taxol in combination with ...
Breaking Medicine Technology:
(Date:4/28/2016)... ... April 28, 2016 , ... Horizon Blue Cross Blue Shield ... hospitals to make transformative changes in how health care is delivered and financed ... in discussing breakthroughs in cellular medicine to treat disease. After accepting an invitation ...
(Date:4/28/2016)... ... April 28, 2016 , ... One way to ignore solid evidence ... unfortunately true. But we toss the baby out with the bathwater when we ignore ... for identifying higher-quality studies and otherwise making better use of education policy research. , ...
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... ... leader in Aesthetic Surgery Education and Anzu®, developers of the AnzuMedical™ Knowledge ... Nationwide Plastic Surgery Collaborative Residency Network. The platform is scheduled to launch in ...
(Date:4/28/2016)... ... April 28, 2016 , ... A first-time look at workers’ compensation claims in ... Workers Compensation Research Institute (WCRI) announced, and that costs per claim were ... Kentucky, 16th Edition , found that indemnity costs per claim and benefit delivery expenses ...
(Date:4/28/2016)... ... April 28, 2016 , ... Metabolic Nutrition today announced ... week’s 2016 Europa Games Get Fit and Sports Expo in Orlando, Florida. ... Orlando Expo coming up April 29-30, was selected as the perfect event to introduce ...
Breaking Medicine News(10 mins):